p27 deregulation in breast cancer: Prognostic significance and implications for therapy

A. Alkarain, R. Jordan, Joyce M Slingerland

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

p27 is a key regulator of G1-to-S phase progression. It prevents premature activation of cyclin E-cdk2 in G1 and promotes the assembly and activation of D-type cyclin-cdks. While the p27 gene is rarely mutated in human cancers, the action of p27 is impaired in breast and other human cancers through accelerated p27 proteolysis, sequestration by cyclin D-cdks, and by p27 mislocalization in tumor cell cytoplasm. Reduced p27 protein is strongly associated with high histopathologic tumor grade, reflecting a lack of tumor differentiation. Loss of p27 is also an indicator of poor patient outcome in a majority of breast cancer studies, including node negative disease. The broad application of p27 in the clinical evaluation of breast cancer prognosis will require a consensus on methods of tumor fixation, staining, and scoring. This review will focus on mechanisms of p27 regulation in normal cells and how deregulation of p27 may arise in breast and other human cancers. The prognostic significance of p27 in human breast cancer and the possible therapeutic implications of these findings will also be reviewed.

Original languageEnglish
Pages (from-to)67-80
Number of pages14
JournalJournal of Mammary Gland Biology and Neoplasia
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Breast Neoplasms
Neoplasms
Cyclin D
Therapeutics
Breast
Cyclin E
S Phase
Proteolysis
Cytoplasm
Staining and Labeling
Genes
Proteins

Keywords

  • Breast cancer
  • Cell cycle
  • p27
  • Prognosis
  • Signal transduction

ASJC Scopus subject areas

  • Cancer Research

Cite this

p27 deregulation in breast cancer : Prognostic significance and implications for therapy. / Alkarain, A.; Jordan, R.; Slingerland, Joyce M.

In: Journal of Mammary Gland Biology and Neoplasia, Vol. 9, No. 1, 01.01.2004, p. 67-80.

Research output: Contribution to journalArticle

@article{be1ad4e9e2564d4c8d475fb4ce2fee92,
title = "p27 deregulation in breast cancer: Prognostic significance and implications for therapy",
abstract = "p27 is a key regulator of G1-to-S phase progression. It prevents premature activation of cyclin E-cdk2 in G1 and promotes the assembly and activation of D-type cyclin-cdks. While the p27 gene is rarely mutated in human cancers, the action of p27 is impaired in breast and other human cancers through accelerated p27 proteolysis, sequestration by cyclin D-cdks, and by p27 mislocalization in tumor cell cytoplasm. Reduced p27 protein is strongly associated with high histopathologic tumor grade, reflecting a lack of tumor differentiation. Loss of p27 is also an indicator of poor patient outcome in a majority of breast cancer studies, including node negative disease. The broad application of p27 in the clinical evaluation of breast cancer prognosis will require a consensus on methods of tumor fixation, staining, and scoring. This review will focus on mechanisms of p27 regulation in normal cells and how deregulation of p27 may arise in breast and other human cancers. The prognostic significance of p27 in human breast cancer and the possible therapeutic implications of these findings will also be reviewed.",
keywords = "Breast cancer, Cell cycle, p27, Prognosis, Signal transduction",
author = "A. Alkarain and R. Jordan and Slingerland, {Joyce M}",
year = "2004",
month = "1",
day = "1",
doi = "10.1023/B:JOMG.0000023589.00994.5e",
language = "English",
volume = "9",
pages = "67--80",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - p27 deregulation in breast cancer

T2 - Prognostic significance and implications for therapy

AU - Alkarain, A.

AU - Jordan, R.

AU - Slingerland, Joyce M

PY - 2004/1/1

Y1 - 2004/1/1

N2 - p27 is a key regulator of G1-to-S phase progression. It prevents premature activation of cyclin E-cdk2 in G1 and promotes the assembly and activation of D-type cyclin-cdks. While the p27 gene is rarely mutated in human cancers, the action of p27 is impaired in breast and other human cancers through accelerated p27 proteolysis, sequestration by cyclin D-cdks, and by p27 mislocalization in tumor cell cytoplasm. Reduced p27 protein is strongly associated with high histopathologic tumor grade, reflecting a lack of tumor differentiation. Loss of p27 is also an indicator of poor patient outcome in a majority of breast cancer studies, including node negative disease. The broad application of p27 in the clinical evaluation of breast cancer prognosis will require a consensus on methods of tumor fixation, staining, and scoring. This review will focus on mechanisms of p27 regulation in normal cells and how deregulation of p27 may arise in breast and other human cancers. The prognostic significance of p27 in human breast cancer and the possible therapeutic implications of these findings will also be reviewed.

AB - p27 is a key regulator of G1-to-S phase progression. It prevents premature activation of cyclin E-cdk2 in G1 and promotes the assembly and activation of D-type cyclin-cdks. While the p27 gene is rarely mutated in human cancers, the action of p27 is impaired in breast and other human cancers through accelerated p27 proteolysis, sequestration by cyclin D-cdks, and by p27 mislocalization in tumor cell cytoplasm. Reduced p27 protein is strongly associated with high histopathologic tumor grade, reflecting a lack of tumor differentiation. Loss of p27 is also an indicator of poor patient outcome in a majority of breast cancer studies, including node negative disease. The broad application of p27 in the clinical evaluation of breast cancer prognosis will require a consensus on methods of tumor fixation, staining, and scoring. This review will focus on mechanisms of p27 regulation in normal cells and how deregulation of p27 may arise in breast and other human cancers. The prognostic significance of p27 in human breast cancer and the possible therapeutic implications of these findings will also be reviewed.

KW - Breast cancer

KW - Cell cycle

KW - p27

KW - Prognosis

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=4344637857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344637857&partnerID=8YFLogxK

U2 - 10.1023/B:JOMG.0000023589.00994.5e

DO - 10.1023/B:JOMG.0000023589.00994.5e

M3 - Article

C2 - 15082919

AN - SCOPUS:4344637857

VL - 9

SP - 67

EP - 80

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 1

ER -